Showing results (141-150 of 741) with videos related to

Sort By:
Pageof 75
Bioorganic & Medicinal Chemistry|December 25, 2012
Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatmentFeng Jin, Dan Gao, Cunlong Zhang, et al.
Bioorganic & Medicinal Chemistry|October 23, 2016
Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapyChao Ding, Shaopeng Chen, Cunlong Zhang, et al.
European Journal of Medicinal Chemistry|February 8, 2011
Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitorsCunlong Zhang, Chunyan Tan, Xuyu Zu, et al.
Breast Cancer Research : BCR|March 12, 2011
Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expressionXuyu Zu, Jun Ma, Hongxia Liu, et al.
Bioorganic & Medicinal Chemistry|June 12, 2017
Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapyZigao Yuan, Shaopeng Chen, Qinsheng Sun, et al.
European Journal of Medicinal Chemistry|April 19, 2017
Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitorsZigao Yuan, Qinsheng Sun, Dan Li, et al.
Molecules (Basel, Switzerland)|April 25, 2012
Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivativesHuaiwei Ding, Zhe Chen, Cunlong Zhang, et al.
Bioorganic & Medicinal Chemistry|March 18, 2015
Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agentsChunmei Gao, Bin Li, Bin Zhang, et al.
Organic & Biomolecular Chemistry|November 16, 2012
Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathwayJinshun Lin, Xiuli Jin, Yiwen Bu, et al.
European Journal of Medicinal Chemistry|January 25, 2021
Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell linesLei Zhao, Tingting Fan, Zhichao Shi, et al.
Pageof 75